{
    "eid": "2-s2.0-85079469667",
    "title": "Increased Levels of Plasma Tumor Necrosis Factor-\u03b1 Mediate Schizophrenia Symptom Dimensions and Neurocognitive Impairments and Are Inversely Associated with Natural IgM Directed to Malondialdehyde and Paraoxonase 1 Activity",
    "cover-date": "2020-05-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Neurology",
            "@code": "2808",
            "@abbrev": "NEUR"
        },
        {
            "@_fa": "true",
            "$": "Cellular and Molecular Neuroscience",
            "@code": "2804",
            "@abbrev": "NEUR"
        }
    ],
    "keywords": [
        "Antioxidants",
        "Cytokines",
        "Inflammation",
        "Oxidative stress",
        "Paraoxonase 1",
        "Psychiatry",
        "Schizophrenia"
    ],
    "authors": [
        "Michael Maes",
        "Sunee Sirivichayakul",
        "Andressa Keiko Matsumoto",
        "Annabel Maes",
        "Ana Paula Michelin",
        "Laura de Oliveira Seme\u00e3o",
        "Jo\u00e3o Victor de Lima Pedr\u00e3o",
        "Estefania G. Moreira",
        "Decio S. Barbosa",
        "Michel Geffard",
        "Andre F. Carvalho",
        "Buranee Kanchanatawan"
    ],
    "citedby-count": 29,
    "ref-count": 50,
    "ref-list": [
        "The macrophage-T-lymphocyte theory of schizophrenia: additional evidence",
        "Schizophrenia: linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression",
        "The role of aberrations in the immune-inflammatory reflex system (IRS) and the compensatory immune-regulatory reflex system (CIRS) in different phenotypes of schizophrenia: The IRS-CIRS theory of schizophrenia",
        "Changes in tryptophan catabolite (TRYCAT) pathway patterning are associated with mild impairments in declarative memory in schizophrenia and deficits in semantic and episodic memory coupled with increased false-memory creation in deficit schizophrenia",
        "A review of vulnerability and risks for schizophrenia: beyond the two hit hypothesis",
        "Neuroprogression in schizophrenia: pathways underpinning clinical staging and therapeutic corollaries",
        "Eotaxin, an endogenous cognitive deteriorating chemokine (ECDC), is a major contributor to cognitive decline in normal people and to executive, memory, and sustained attention deficits, formal thought disorders, and psychopathology in schizophrenia patients",
        "A new schizophrenia model: immune activation is associated with induction of different neurotoxic products which together determine memory impairments and schizophrenia symptom dimensions",
        "In schizophrenia, increased plasma IgM/IgA responses to gut commensal bacteria are associated with negative symptoms, neurocognitive impairments, and the deficit phenotype",
        "Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways",
        "The compensatory immune-regulatory reflex system (CIRS) in depression and bipolar disorder",
        "Activation of the immune-inflammatory response system and the compensatory immune-regulatory system in antipsychotic naive first-episode psychosis",
        "In schizophrenia, deficits in natural IgM Isotype antibodies including those directed to malondialdehyde and azelaic acid strongly predict negative symptoms, neurocognitive impairments, and the deficit syndrome",
        "Deficit schizophrenia is characterized by defects in IgM-mediated responses to tryptophan catabolites (TRYCATs): a paradigm shift towards defects in natural self-regulatory immune responses coupled with mucosa-derived TRYCAT pathway activation",
        "Emerging role of innate B1 cells in the pathophysiology of autoimmune and neuroimmune diseases: association with inflammation, oxidative and nitrosative stress and autoimmune responses",
        "Naturally occurring IgM antibodies to oxidation-specific epitopes",
        "The innate immune response to products of phospholipid peroxidation",
        "Natural and adaptive IgM antibodies in the recognition of tumor-associated antigens of breast cancer (review)",
        "Human IgM antibodies to malondialdehyde conjugated with albumin are negatively associated with cardiovascular disease among 60-year-olds",
        "Autoimmunity: do IgM antibodies protect against atherosclerosis in SLE?",
        "Why should psychiatrists and neuroscientists worry about paraoxonase 1?",
        "Lowered paraoxonase 1 (PON1) activity is associated with increased cytokine levels in drug na\u00efve first-episode psychosis",
        "The schedule for the deficit syndrome: an instrument for research in schizophrenia",
        "The validity of the mini international neuropsychiatric interview (M.I.N.I.) Thai version",
        "The scale for the assessment of negative symptoms (SANS): conceptual and theoretical foundations",
        "The positive and negative syndrome scale (PANSS) for schizophrenia",
        "The brief psychiatric rating scale",
        "A rating scale for depression",
        "The neuro-immune fingerprint of major neuro-cognitive psychosis or deficit schizophrenia: A supervised machine learning study",
        "Circulating antibodies directed against conjugated fatty acids in sera of patients with multiple sclerosis",
        "Autoantibodies to malondialdehyde-modified epitope in connective tissue diseases and vasculitides",
        "Determination of paraoxonase 1 status without the use of toxic organophosphate substrates",
        "Controlling the false discovery rate: a practical and powerful approach to multiple testing",
        "Structural equation modeling with the SmartPLS",
        "Neurotoxic effects of tumor necrosis factor-alpha in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtype: Implications for AIDS neuropathogenesis",
        "Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner",
        "Tumor necrosis factor-alpha: a link between neuroinflammation and excitotoxicity",
        "Targeting classical IL-6 signaling or IL-6 trans-signaling in depression?",
        "The role of interleukin-6 signaling in nervous tissue",
        "Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse",
        "Neuroimmunology of the interleukins 13 and 4",
        "IL-4 in the brain: a cytokine to remember",
        "Breakdown of the paracellular tight and adherens junctions in the gut and blood-brain barrier and damage to the vascular barrier in patients with deficit schizophrenia",
        "Psychosis-related matricide associated with a lesion of the ventromedial prefrontal cortex",
        "Executive functioning in schizophrenia"
    ],
    "affiliation": [
        {
            "affiliation-city": "Plovdiv",
            "@id": "60031890",
            "affilname": "Medical University of Plovdiv",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031890",
            "affiliation-country": "Bulgaria"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Londrina",
            "@id": "60027866",
            "affilname": "Universidade Estadual de Londrina",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027866",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Geelong",
            "@id": "60018805",
            "affilname": "Deakin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018805",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Toronto",
            "@id": "60015765",
            "affilname": "Centre for Addiction and Mental Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015765",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "New Brunswick",
            "@id": "60010584",
            "affilname": "Johnson &amp; Johnson",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010584",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Talence",
            "@id": "101932858",
            "affilname": "IDRPHT",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/101932858",
            "affiliation-country": "France"
        }
    ],
    "funding": [
        "Asahi Glass Foundation",
        "Chulalongkorn University",
        "Faculty of Medicine, Chulalongkorn University"
    ]
}